If you find any of the dividend record is wrong or duplicated, please contact me.
| Year | Yield | Total | Amount | Ex Date | Pay Date | Particulars |
|---|---|---|---|---|---|---|
| 2024 | 3.07% | SGD 0.009 | SGD0.0086 | 2024-05-08 | 2024-05-24 | Rate: SGD 0.0086 Per Security |
| 2023 | 16.82% | SGD 0.047 | SGD0.036 | 2023-08-17 | 2023-08-31 | Rate: SGD 0.036 Per Security |
| SGD0.0111 | 2023-05-10 | 2023-05-24 | Rate: SGD 0.0111 Per Security | |||
| 2022 | 2.39% | SGD 0.007 | SGD0.0067 | 2022-05-12 | 2022-05-25 | Rate: SGD 0.0067 Per Security |
| 2021 | 2.21% | SGD 0.006 | SGD0.0062 | 2021-05-10 | 2021-05-25 | Rate: SGD 0.0062 Per Security |
| 2020 | 3.57% | SGD 0.01 | SGD0.01 | 2020-05-22 | 2020-06-08 | Rate: SGD 0.01 Per Security |
| 2019 | 1.96% | SGD 0.006 | SGD0.0055 | 2019-05-10 | 2019-05-24 | Rate: SGD 0.0055 Per Security |
ListedDate: 18 May 2018 on Catalist
The share price is in SGD. The dividends are paid in SGD
Address: 16 Tai Seng Street , #04-01, Singapore 534138
Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapores leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Groups regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based. The Groups core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.
© 2024 Dividends.sg / More Countries